For people with lung cancer, exercise can be grueling, but evidence of benefits is growing
When you think of lung cancer treatment, what comes to mind—chemotherapy, radiation, surgery? While these can be crucial, ...
JD Supra2h
Novacure’s Wearable Lung Cancer Treatment Device, Optune Lua, Receives FDA Approval
The FDA has granted approval for Novocure‘s wearable medical device, Optune Lua, designed to treat advanced non-small cell ...
Managed Healthcare Executive2d
Animal Study Hints That GABA(A) Receptors Could Be Key To Enhancing Treatment of Lung Cancer That Has Spread to the Brain
What’s more, AM-101 improved radiation treatment, slowing down the growth of NSCLC subcutaneous xenograft tumors in mice, by ...
MassDevice1d
Novocure wins FDA nod for lung cancer treatment wearable
Novocure announced on Tuesday that the FDA treated its Optune Lua wearable device for treating metastatic non-small cell lung ...
For people with lung cancer, exercise can be gruelling. It’s also among the most important things
Research shows regular physical activity can significantly improve quality of life for lung cancer patients. This includes ...
medtechdive2h
Novocure wins FDA approval for electric field device in lung cancer
Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.
GlobalData on MSN1d
NovoCure scoops FDA approval on wearable for metastatic cancer treatment
Optune Lua received FDA approval based on data from the pivotal LUNAR trial which demonstrated significant median OS ...
The American Journal of Managed Care7h
Expanding Access to NSCLC Innovations: Challenges and Opportunities
The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and ...
Business Wire2d
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...
Understanding how deadly lung cancers control the local immune system
Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune ...
Targeted Oncology1h
Pembrolizumab/Chemo Continues to Impress in NSCLC With 5-Year Updates
During a Case-Based Roundtable® event, Ticiana Leal, MD, discusses phase 3 trials of combinations in the non–small cell lung ...
Cure Today1d
Incidence of Cardiovascular Disease May Increase in Older Adults With Cancer
Aspirin did not impact CVD incidence; however, risk may be higher in those with metastatic, hematological and lung cancer and ...